Search for:
Skip to content
Main Navigation
Careers
Partnerships
Investors
Contact
Search
About Us
Overview
Founding Story
Vision, Mission, and Values
People & Culture
The Founders
Leadership
Scientific Advisory Board
Board of Directors
Our Approach
Overview
The Autoimmune Problem
Our Concept
Disease States
Our Science
Publications
Manufacturing
Platform & Pipeline
Overview
Platform
Pipeline
Patients & Care Partners
Overview
The Autoimmune Problem
Clinical Trials
Medical Professionals
Overview
The Autoimmune Problem
Publications
Clinical Trials
News
Overview
Press Releases
In the News
Publications
Chimeric cytokine receptor provides IL-2 signaling for engineered regulatory T cell therapy
Array
•
Opportunities for T
reg
cell therapy for the treatment of human disease
Array
•
Polyclonal Regulatory T Cell Manufacturing Under cGMP: A Decade of Experience
Array
•
Immunotherapy: Building a bridge to a cure for type 1 diabetes
Array
•
Foxp3: a genetic foundation for regulatory T cell differentiation and function
Array
•
Treg cell-based therapies: challenges and perspectives
Array
•
Next-generation regulatory T cell therapy
Array
•
Therapeutic use of regulatory T cells for graft-versus-host disease
Array
•
Regulatory T-cell therapy for autoimmune and autoinflammatory diseases: The next frontier
Array
•